Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding TrialJohn A. Todd, Frank Waldron-Lynch, Linsey Porter et al.|PLoS Medicine|2016Cited by 140
An evaluation of Bayesian designs for dose-escalation studies in healthy volunteersJohn Whitehead, Andrew Wright, Yinghui Zhou et al.|Statistics in Medicine|2005Cited by 27
Development process of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE (DosE FIndiNg Extensions) studyOlga Solovyeva, Christina Yap, Munyaradzi Dimairo et al.|Unknown|2023Cited by 0